References
- Rowinsky EK, Cazenave LA, Donehower RC. Taxol: a novel investigational antimicrotubule agent. J Natl Cancer Inst 1990; 82: 1247–59.
- Runowicz CD, Wiernik PH, Einzig AT. Taxol in ovarian cancer. Cancer 1993; 71: 1591–6.
- Arbuck SG, Blaylock BA. Taxol: clinical results and current issues in development. In: Suffness M, ed. Taxol: science and applications. Boca Raton, FL: CRC Press, 1995: 379–415
- Forastiere AA. Paclitaxel (Taxol) for the treatment of head and neck cancer. Semin Oncol 1994; 21: 49–52.
- Frei E III. Combination cancer therapy: presidential address. Cancer Res 1972; 32: 2593–607.
- Horwitz SB. Mechanism of action of Taxol. Trends Pharmacol Sci 1992; 13: 134–6.
- Horwitz SB. Taxol (paclitaxel). Mechanism of action. Ann Oncol 1994; 5: 53–6.
- Cook JA, Teague D, Fisher J. Radiosensitization of Chinese hamster V79 cells by taxol. Radiat Oncol Invest 1993; 1: 103–10.
- Sinclair WK. Cyclic X-ray responses in mammalian cells in vitro. Radiat Res 1968; 33: 620–43.
- Tishler RB, Schiff PB, Geard CR, Hall EJ. Taxol: a novel radiation sensitizer. Int J Radiat Oncol Biol Phys 1992; 22: 613–7.
- Zenner HP, Lehner W, Herrmann IF. Establishment of carcinoma cell lines from larynx and submandibular gland. Arch Otorhinolaryngol 1979; 225: 269–77.
- Rownisky EK, Donehower RC, Jones RJ, Tucker RW. Microtubule changes and cytotoxicity in leukaemic cell lines treated with taxol. Cancer Res 1988; 48: 4093–100.
- Tishler RB, Geard CR, Hall EJ, Schiff PB. Taxol sensitizes human astrocytoma cells to radiation. Cancer Res 1992; 52: 3495–7.
- Hanauske AR, Degen D, Hilsenbeck SG. Effects of taxotere and taxol on in vitro colony formation of freshly explanted tumor cells. Anticancer Drugs 1992; 3: 121–4.
- Elomaa L, Joensuu H, Kulmala J. Squamous cell car-cinoma is highly sensitive to taxol, a possible new radiation sensitizer. Acta Otolaryngol (Stockh) 1995; 115: 340–4.
- Matsuoka H, Furusawa M, Tomoda H, Seo Y. Differ-ence in cytotoxicity of paclitaxel against neoplastic and normal cells. Anticancer Res 1994; 14: 163–7.
- Choy H, Rodriguez FF, Koester S. Investigation of taxol as a potential radiation sensitizer. Cancer 1993; 71: 3774–8.
- Liebmann J, Cook JA, Fisher J. Changes in radiation survival curve parameters in human tumour and ro-dent cells exposed to paclitaxel (Taxol®). Int J Radiat Oncol Biol Phys 1994; 29: 559–64.
- Steren A, Sevin B, Perras J. Taxol sensitizes human ovarian cancer cells to radiation. Gynecol Oncol 1993; 48: 252–8.
- Geard CR, Jones JM. Radiation and taxol effects on synchronized human cervical carcinoma cells. Int J Radiat Oncol Biol Phys 1994; 29: 565–9.
- Geard CR, Jones JM, Schiff PB. Taxol and radiation. J Natl Cancer Inst 1993; 15: 89–94.
- Jagetia GC, Adiga SK. Influence of various concentra-tions of taxol on cell survival, micronuclei induction, and LDH activity in cultured V79 cells. Cancer Lett 1995; 96: 195–200.
- Jordan MA, Wendell K, Gardiner S. Mitotic block induced in HeLa cells by low concentrations of pacli-taxel (taxol) results in abnormal mitotic exit and apop-totic cell death. Cancer Res 1996; 56: 816–25.
- Shibamoto Y, Shibata T, Miyatake S. Assessment of the proliferative activity and radiosensitivity of human tumours using the cytokinesis-block micronucleus as-say. Br J Cancer 1994; 70: 67–71.
- Streffer C. Is the micronucleus assay predictive for cellular radiosensitivity? Br J Radiol 1992; 24: 70–3.